Phase of Trial: Phase II
Latest Information Update: 11 Dec 2014
At a glance
- Drugs Anrukinzumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 22 Jun 2008 Actual end date is May 2008 as reported by ClinicalTrials.gov.
- 22 Jun 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.